EXC vs NRXS · P/E 17, rev $24.26B vs rev $3.6M
Exelon Corporation (EXC) versus Neuraxis, Inc. (NRXS) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. NRXS currently screens at market cap $83.1M.
Not investment advice. Open the EXC and NRXS stock pages for the full models.
Not investment advice.